Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties Track

[11C]Methionine PET metabolic imaging of low grade CNS tumors in children and young adults.

Mikhail Doubrovin, Scott Snyder, Elizabeth Butch and Barry Shulkin
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 433;
Mikhail Doubrovin
1Diagnostic Imaging St. Jude Children's Research Hospital Memphis TN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Snyder
1Diagnostic Imaging St. Jude Children's Research Hospital Memphis TN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Butch
1Diagnostic Imaging St. Jude Children's Research Hospital Memphis TN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry Shulkin
1Diagnostic Imaging St. Jude Children's Research Hospital Memphis TN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

433

Objectives PET imaging of brain tumors with amino acid-based radiotracers provides the advantage of a low background activity in the cortex and white matter not affected by the disease. In the current study, we examined the ability of PET with [11C]methionine (METPET) to visualize low grade CNS tumors in children and young adults.

Methods The study included 41 patients with age range from 4 to 27 years (17 male, 24 female). 18 patients had METPET performed at the primary diagnosis. 23 patients underwent study at the time of known or suspected recurrence. After a 4 hour or longer fast, patients were injected intravenously with 20 mCi (740MBq) [11C]methionine/1.7 sq m body surface area (prepared under IND specified conditions). Approximately 5 minutes later, CT of the head was obtained for attenuation correction, followed by emission imaging for 15 min in 3D mode. Images were reconstructed using vendor supplied software. Two experienced nuclear medicine physicians reviewed images using quantitative (SUVmax) and qualitative approaches with comparison to MRI.

Results At diagnosis, 12 of 18 patients had uptake within the tumor at least 2 times greater than the white matter background. In the initial scans of the patients with known or suspected recurrent disease, tumor uptake was greater than the background in 19 out of 23 patients. Table 1 depicts the tumor to background ratios for patients at initial diagnosis and for those with recurrent disease. Tumor uptake tended to be slightly higher in previously treated patients. In four patients, methionine uptake did not differ significantly from the background. In 2 patients a contemporary [18F]FDG PET was also performed. In both cases, METPET provided significant improvement in tumor visualization and tumor/background ratio (Picture 1).

Conclusions : In most patients with low grade CNS tumors, PET with [11C]methionine provides a high quality functional imaging tool for metabolic characterization. Uptake was elevated in both newly diagnosed patients and in those with recurrent disease. The low background activity in both cerebral gray and white matter facilitates tumor detection. Serial studies will determine the utility of the technique in assessing prognosis, response to therapy, monitoring for tumor recurrence, and distinguishing recurrent tumor from radiation necrosis. $$graphic_613DC5E1-56AD-4064-8973-23939E4A339B$$

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[11C]Methionine PET metabolic imaging of low grade CNS tumors in children and young adults.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[11C]Methionine PET metabolic imaging of low grade CNS tumors in children and young adults.
Mikhail Doubrovin, Scott Snyder, Elizabeth Butch, Barry Shulkin
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 433;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[11C]Methionine PET metabolic imaging of low grade CNS tumors in children and young adults.
Mikhail Doubrovin, Scott Snyder, Elizabeth Butch, Barry Shulkin
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 433;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties Track

  • Quantitative Evaluation of Parathyroid Adenoma and Hyperplasia in Reference to Thyroid using Tc-99m MIBI SPECT/CT
  • A primitive study for clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms
  • Role of 18F-FDG PET/CT in detection of disease burden and response assessment in patients with myeloid sarcoma
Show more General Clinical Specialties Track

Pediatric Nuclear Medicine

  • Application of Statistical Parametric Mapping in Children with Medically Intractable Epilepsy
  • Baseline Metabolic Tumor Volume Measured by FDG PET/CT Before Neoadjuvant Chemotherapy Predicts Survival in Pediatric Osteosarcoma
Show more Pediatric Nuclear Medicine

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire